Identifying monoclonal gammopathy of undetermined significance from electronic health records-Reference-Cited by-同舟云学术

Identifying monoclonal gammopathy of undetermined significance from electronic health records

Published:2022-12-04 Issue:3 Volume:6 Page:
ISSN:2573-8348
Container-title:Cancer Reports
language:en
Short-container-title:Cancer Reports

Author:

Tanenbaum Hilary C.¹²^ORCID,Birmann Brenda M.³,Bertrand Kimberly A.⁴,Teras Lauren R.⁵,Krishnan Amrita Y.⁶,Pourhassan Hoda⁶,Goldsmith Scott⁶,Cannavale Kimberly¹,Wang Sophia S.⁶,Chao Chun R.¹^ORCID

Affiliation:

1. Department of Research & Evaluation Kaiser Permanente Southern California Pasadena California USA

2. Scientific Research & Development Embark Veterinary Ithaca New York USA

3. Channing Division of Network Medicine, Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston Massachusetts USA

4. Slone Epidemiology Center Boston University Boston Massachusetts USA

5. Intramural Research Department American Cancer Society Atlanta Georgia USA

6. City of Hope Medical Center California USA

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cnr2.1755

Reference15 articles.

1. Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM)

2. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

3. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

4. Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study

5. Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study